Indopoly Swakarsa Industry Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Indopoly Swakarsa Industry Tbk trades at Rp106 (market cap 689.44B, 236.1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Indopoly Swakarsa Industry Tbk is far larger — about 4.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Indopoly Swakarsa Industry Tbk is more actively traded (236.1K versus 96.7K). Which is the better fit depends on your goals.
| IPOL | OBAT | |
|---|---|---|
Market Cap | 689.44B | 167.37B |
Volume | 236.1K | 96.7K |
Lot | 2.36K | 967 |
Turnover | 25.04M | 23.82M |
Average Price | 106.05 | 246.34 |
Value | 25.04M | 23.82M |
Indicative Equilibrium Price | 106 | 248 |
Indicative Equilibrium Volume | 18 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indopoly Swakarsa Industry (the company) was established on 24 Mar 1995 based on Notaries Deed No. 114 and the deed of establishment was approved by the the Ministry of Justice dated Dec 22, 1995. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Popie Savitri, S.H., dated Mar 1, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on IPOL →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →